Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Patologia Clínica
2020-07-01
|
Series: | Jornal Brasileiro de Patologia e Medicina Laboratorial |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=en |
_version_ | 1818743889678303232 |
---|---|
author | David Felipe B. Araújo Iago D. L. Cavalcanti Bruna R. Larrazabal-Hadj-Idris Adrya Lúcia Peres |
author_facet | David Felipe B. Araújo Iago D. L. Cavalcanti Bruna R. Larrazabal-Hadj-Idris Adrya Lúcia Peres |
author_sort | David Felipe B. Araújo |
collection | DOAJ |
description | ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented. |
first_indexed | 2024-12-18T02:35:35Z |
format | Article |
id | doaj.art-6ff26af5ebbe47c39bf130922e4d3709 |
institution | Directory Open Access Journal |
issn | 1678-4774 |
language | English |
last_indexed | 2024-12-18T02:35:35Z |
publishDate | 2020-07-01 |
publisher | Sociedade Brasileira de Patologia Clínica |
record_format | Article |
series | Jornal Brasileiro de Patologia e Medicina Laboratorial |
spelling | doaj.art-6ff26af5ebbe47c39bf130922e4d37092022-12-21T21:23:48ZengSociedade Brasileira de Patologia ClínicaJornal Brasileiro de Patologia e Medicina Laboratorial1678-47742020-07-015610.5935/1676-2444.20200038Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancerDavid Felipe B. Araújohttps://orcid.org/0000-0003-3747-6988Iago D. L. CavalcantiBruna R. Larrazabal-Hadj-IdrisAdrya Lúcia PeresABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=enneoplasmantineoplastichematologytoxicity |
spellingShingle | David Felipe B. Araújo Iago D. L. Cavalcanti Bruna R. Larrazabal-Hadj-Idris Adrya Lúcia Peres Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer Jornal Brasileiro de Patologia e Medicina Laboratorial neoplasm antineoplastic hematology toxicity |
title | Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
title_full | Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
title_fullStr | Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
title_full_unstemmed | Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
title_short | Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
title_sort | hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer |
topic | neoplasm antineoplastic hematology toxicity |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421&tlng=en |
work_keys_str_mv | AT davidfelipebaraujo hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer AT iagodlcavalcanti hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer AT brunarlarrazabalhadjidris hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer AT adryaluciaperes hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer |